查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1517429

全球医疗应用生物聚合物市场规模研究，按类型、来源、应用和区域预测 2022-2032

Global Biopolymers for Medical Applications Market Size Study, by Type, by Source, by Application, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 200 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球医疗应用生物聚合物市场价值约为24.3亿美元，预计在2024-2032年预测期内将以超过23.24%的健康成长率成长。生物聚合物是天然或生物合成的聚合物，对于製造尖端医疗工具和设备至关重要，例如可生物降解的支架、药物传输系统和缝合线，因其与人体的相容性、自然分解和降低的毒性而受到讚赏。由于对生物相容性材料的需求激增和突破性的技术进步，它们的应用广泛，涵盖再生医学、製药和外科手术。市场充满机会，生产效率方面有望取得进步，以及具有刺激响应性等智慧功能特性的新型生物聚合物。然而，该产业面临许多限制，包括高昂的研发成本、严格的监管环境以及来自合成聚合物的竞争。

慢性病盛行率的上升和老年人口的增加大大增加了医疗应用中生物聚合物的市场需求。此外，创新和研究至关重要，重点是开发满足特定医疗需求的客製化生物聚合物，并优化性能以适应临床应用。探索永续生产方法并与医疗保健实体建立牢固的关係也有助于推动这一令人兴奋的领域的发展。监管支持和生物聚合物研发投资的增加进一步支持了市场，旨在增强生物相容性、生物功能性、机械性能、降解率和免疫原性。

全球医疗应用生物聚合物市场研究考虑的关键区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于医疗生物聚合物消费的成长和创新、强大的医疗基础设施、先进的医疗设施以及对永续材料的高度重视等因素，北美在医疗应用生物聚合物市场上处于领先地位。然而，在多样化的消费者需求和庞大的农业足迹的推动下，预计亚太地区的市场在预测期内将以最快的速度成长。

目录

第 1 章：全球医疗应用生物聚合物市场执行摘要

  • 全球医疗应用生物聚合物市场规模及预测（2022-2032）
  • 区域概要
  • 分部摘要
    • 按类型
    • 按来源
    • 按申请
  • 主要趋势
  • 经济衰退的影响
  • 分析师推荐与结论

第 2 章：全球医疗应用生物聚合物市场定义与研究假设

  • 研究目的
  • 市场定义
  • 研究假设
    • 包容与排除
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（消费者的角度）
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者意识和接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第 3 章：全球医疗应用生物聚合物市场动态

  • 市场驱动因素
    • 生物相容性材料需求激增
    • 生物聚合物的技术进步
    • 慢性病盛行率上升
  • 市场挑战
    • 研发成本高
    • 严格的监管环境
    • 来自合成聚合物的竞争
  • 市场机会
    • 生产效率和新型生物聚合物的进步
    • 永续生产方法

第 4 章：全球医疗应用生物聚合物市场产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
    • 波特五力模型的未来方法
    • 波特的 5 力影响分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章：2022-2032 年全球医疗应用生物聚合物市场规模及类型预测

  • 细分仪表板
  • 全球医疗应用生物聚合物市场：类型收入趋势分析，2022 年和 2032 年
    • 生物基聚乙烯
    • 可生物降解淀粉混合物
    • 生物PC
    • 生物PET
    • 生物聚氨酯
    • 纤维素衍生物
    • PHA
    • 再生纤维素

第 6 章：2022-2032 年全球医疗应用生物聚合物市场规模及来源预测

  • 细分仪表板
  • 全球医疗应用生物聚合物市场：2022 年和 2032 年来源收入趋势分析
    • 自然的
    • 合成的

第 7 章：2022-2032 年全球医疗应用生物聚合物市场规模及应用预测

  • 细分仪表板
  • 全球医疗应用生物聚合物市场：2022 年和 2032 年应用收入趋势分析
    • 生物可吸收支架
    • 牙科
    • 药物输送系统
    • 治疗产品
    • 外科植入装置
    • 治疗影像
    • 伤口闭合

第 8 章：2022-2032 年全球医疗应用生物聚合物市场规模及按地区预测

  • 北美医疗应用生物聚合物市场
    • 美国医疗应用生物聚合物市场
      • 2022-2032 年型别细分规模与预测
      • 2022-2032 年来源细分规模与预测
      • 2022-2032 年应用细分规模与预测
    • 加拿大医疗应用生物聚合物市场
  • 欧洲医疗应用生物聚合物市场
    • 英国医疗应用市场生物聚合物
    • 德国医疗应用市场生物聚合物
    • 法国医疗应用生物聚合物市场
    • 西班牙医疗应用生物聚合物市场
    • 义大利医疗应用生物聚合物市场
    • 欧洲其他地区医疗应用生物聚合物市场
  • 亚太地区医疗应用生物聚合物市场
    • 中国医疗应用生物聚合物市场
    • 印度医疗应用生物聚合物市场
    • 日本医疗应用生物聚合物市场
    • 澳洲医疗应用生物聚合物市场
    • 韩国医疗应用市场生物聚合物
    • 亚太地区其他地区医疗应用生物聚合物市场
  • 拉丁美洲医疗应用市场的生物聚合物
    • 巴西医疗应用市场生物聚合物
    • 墨西哥医疗应用市场生物聚合物
    • 拉丁美洲其他地区医疗应用生物聚合物市场
  • 中东和非洲医疗应用市场的生物聚合物
    • 沙乌地阿拉伯医疗应用市场的生物聚合物
    • 南非医疗应用生物聚合物市场
    • 中东和非洲其他地区的医疗应用生物聚合物市场

第 9 章：竞争情报

  • 重点企业SWOT分析
  • 顶级市场策略
  • 公司简介
    • BASF SE
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 市场策略
    • Biesterfeld AG
    • BioPolymer GmbH & Co. KG
    • Blafar Ltd.
    • Corbion NV
    • Danimer Scientific, Inc.
    • DuPont de Nemours, Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Geistlich Pharma AG
    • GELITA AG
    • Green Dot Bioplastics Inc.
    • HTL
    • HyMedPoly
    • Invibio Ltd. by Victrex PLC

第 10 章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性
简介目录

Global Biopolymers for Medical Applications Market is valued at approximately USD 2.43 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 23.24% over the forecast period 2024-2032. Biopolymers are natural or biologically synthesized polymers, essential in the creation of cutting-edge medical tools and devices, such as biodegradable stents, drug delivery systems, and sutures, admired for their compatibility with the human body, natural decomposition, and reduced toxicity. Their diverse applications span regenerative medicine, pharmaceuticals, and surgical procedures, driven by the surging need for biocompatible materials and groundbreaking technological progression. The market teems with opportunities, promising advances in production efficiency and novel biopolymers featuring smart functional properties like stimuli-responsiveness. However, the industry faces constraints including the steep costs of research and development, stringent regulatory landscapes, and competition from synthetic polymers.

The rising prevalence of chronic diseases and a growing elderly population significantly contribute to the market demand for biopolymers in medical applications. Additionally, innovation and research are pivotal, focusing on developing tailored biopolymers for specific medical needs and optimizing performance to align with clinical applications. Exploring sustainable production methods and forging strong relationships with healthcare entities are also instrumental in advancing this exciting field. The market is further bolstered by regulatory support and increasing investments in biopolymer R&D, aimed at enhancing biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity.

Key regions considered for the global Biopolymers for Medical Applications market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. The North America leads the Biopolymers for Medical Applications market owing to factors such as rise in consumption and innovation in biopolymers for medical, robust medical infrastructure, advanced healthcare facilities, and a strong focus on sustainable materials. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by diverse consumer needs and significant agricultural footprints.

Major market players included in this report are:

  • BASF SE
  • Biesterfeld AG
  • BioPolymer GmbH & Co. KG
  • Blafar Ltd.
  • Corbion NV
  • Danimer Scientific, Inc.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • Evonik Industries AG
  • Geistlich Pharma AG
  • GELITA AG
  • Green Dot Bioplastics Inc.
  • HTL
  • HyMedPoly
  • Invibio Ltd. by Victrex PLC

The detailed segments and sub-segment of the market are explained below:

By Type:

  • Bio-Based Polyethylene
  • Bio-Degradable Starch Blends
  • Bio-PC
  • Bio-PET
  • Bio-PUR
  • Cellulose Derivatives
  • PHA
  • Regenerated Cellulose

By Source:

  • Natural
  • Synthetic

By Application:

  • Bioresorbable Scaffolds
  • Dentistry
  • Drug Delivery Systems
  • Healing Products
  • Surgical Implant Devices
  • Therapeutic Imaging
  • Wound Closure

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Biopolymers for Medical Applications Market Executive Summary

  • 1.1. Global Biopolymers for Medical Applications Market Size & Forecast (2022- 2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Source
    • 1.3.3. By Application
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Biopolymers for Medical Applications Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Biopolymers for Medical Applications Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Surging demand for biocompatible materials
    • 3.1.2. Technological advancements in biopolymers
    • 3.1.3. Rising prevalence of chronic diseases
  • 3.2. Market Challenges
    • 3.2.1. High costs of research and development
    • 3.2.2. Stringent regulatory landscapes
    • 3.2.3. Competition from synthetic polymers
  • 3.3. Market Opportunities
    • 3.3.1. Advances in production efficiency and novel biopolymers
    • 3.3.2. Sustainable production methods

Chapter 4. Global Biopolymers for Medical Applications Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Biopolymers for Medical Applications Market Size & Forecasts by Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Biopolymers for Medical Applications Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Bio-Based Polyethylene
    • 5.2.2. Bio-Degradable Starch Blends
    • 5.2.3. Bio-PC
    • 5.2.4. Bio-PET
    • 5.2.5. Bio-PUR
    • 5.2.6. Cellulose Derivatives
    • 5.2.7. PHA
    • 5.2.8. Regenerated Cellulose

Chapter 6. Global Biopolymers for Medical Applications Market Size & Forecasts by Source 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Biopolymers for Medical Applications Market: Source Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Natural
    • 6.2.2. Synthetic

Chapter 7. Global Biopolymers for Medical Applications Market Size & Forecasts by Application 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Biopolymers for Medical Applications Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Bioresorbable Scaffolds
    • 7.2.2. Dentistry
    • 7.2.3. Drug Delivery Systems
    • 7.2.4. Healing Products
    • 7.2.5. Surgical Implant Devices
    • 7.2.6. Therapeutic Imaging
    • 7.2.7. Wound Closure

Chapter 8. Global Biopolymers for Medical Applications Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Biopolymers for Medical Applications Market
    • 8.1.1. U.S. Biopolymers for Medical Applications Market
      • 8.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Source breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Biopolymers for Medical Applications Market
  • 8.2. Europe Biopolymers for Medical Applications Market
    • 8.2.1. U.K. Biopolymers for Medical Applications Market
    • 8.2.2. Germany Biopolymers for Medical Applications Market
    • 8.2.3. France Biopolymers for Medical Applications Market
    • 8.2.4. Spain Biopolymers for Medical Applications Market
    • 8.2.5. Italy Biopolymers for Medical Applications Market
    • 8.2.6. Rest of Europe Biopolymers for Medical Applications Market
  • 8.3. Asia-Pacific Biopolymers for Medical Applications Market
    • 8.3.1. China Biopolymers for Medical Applications Market
    • 8.3.2. India Biopolymers for Medical Applications Market
    • 8.3.3. Japan Biopolymers for Medical Applications Market
    • 8.3.4. Australia Biopolymers for Medical Applications Market
    • 8.3.5. South Korea Biopolymers for Medical Applications Market
    • 8.3.6. Rest of Asia Pacific Biopolymers for Medical Applications Market
  • 8.4. Latin America Biopolymers for Medical Applications Market
    • 8.4.1. Brazil Biopolymers for Medical Applications Market
    • 8.4.2. Mexico Biopolymers for Medical Applications Market
    • 8.4.3. Rest of Latin America Biopolymers for Medical Applications Market
  • 8.5. Middle East & Africa Biopolymers for Medical Applications Market
    • 8.5.1. Saudi Arabia Biopolymers for Medical Applications Market
    • 8.5.2. South Africa Biopolymers for Medical Applications Market
    • 8.5.3. Rest of Middle East & Africa Biopolymers for Medical Applications Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. BASF SE
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Biesterfeld AG
    • 9.3.3. BioPolymer GmbH & Co. KG
    • 9.3.4. Blafar Ltd.
    • 9.3.5. Corbion NV
    • 9.3.6. Danimer Scientific, Inc.
    • 9.3.7. DuPont de Nemours, Inc.
    • 9.3.8. Eastman Chemical Company
    • 9.3.9. Evonik Industries AG
    • 9.3.10. Geistlich Pharma AG
    • 9.3.11. GELITA AG
    • 9.3.12. Green Dot Bioplastics Inc.
    • 9.3.13. HTL
    • 9.3.14. HyMedPoly
    • 9.3.15. Invibio Ltd. by Victrex PLC

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes